Clinical Trial: Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns: A Randomized Placebo Controlled Trial
Brief Summary: The purpose of this study is to to study the role of oral Sildenafil in Persistent Pulmonary Hypertension of Newborn (PPHN) secondary to Meconium Aspiration Syndrome (MAS) in newborns and to study risk factors of MAS developing into PPHN.
Detailed Summary:
Sponsor: Sir Takhtasinhji General Hospital
Current Primary Outcome: Improvement in oxygen saturation (SpO2) [ Time Frame: 26 hours, 50 hours ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Oxygenation index [ Time Frame: 26 hours, 50 hours ]
Original Secondary Outcome: Same as current
Information By: Sir Takhtasinhji General Hospital
Dates:
Date Received: December 18, 2012
Date Started: December 2011
Date Completion:
Last Updated: June 24, 2014
Last Verified: June 2014